
		Search for:

UMDNJ technologies available for licensing

Oncology

Combined Oncology Summaries

A Novel Class of mTOR Inhibitors

A Novel Topoisomerase 1 Binding Protein for Use in Cancer Diagnostics and Therapeutics

Activated CDC42-Associated Kinase (Ack) as a Therapeutic Target for Ras Induced Cancer

Apoptosis-inducing peptides as novel therapeutics for cancer treatment

Bone Morphogenetic Protein –2 and Protein-4 in Treatment and Diagnosis of Cancer

dUTPase Enzyme A Marker for Cellular Proliferation Background

EMAP II in Cancer Therapy

Epigenetic Modulation for Restoration of Drug Sensitivity in Cancer Chemotherapy

Hematopoietic Growth Factor Inducible Neurokinin-1 Gene

Identification of a Myeloid Precursor Cell for Modulations of Immune Responses

Method of Improving Drugs with Anti-Retroviral and Anti-Cancer Activity

Monoclonal Antibody for a Prostate-Specific Tumor Suppressor Gene

Mouse Model of Invasive Bladder Cancer

Novel Bi-Functional Alpha-Kinases Protein Kinases Linked to Ion Channels

Novel Combretastatin A-4 Analogues with Potent Cytotoxicity and Anti-Tubulin

Novel Leukotoxin as a Therapeutic Agent

Novel Modification of Immunomodulatory Protein

Oligonucleotide Compositions for the inhibition of Transcription Factors

PNA-Neamine Conjugates for use as Therapeutic agents and Research Tools

Reversal of Resistance to Anti-Microtubule Drugs in Human Breast Cancer

Thymidylate Synthase Polymorphisms for Use in Screening for Cancer Susceptibility

OPL News Items

11-7-07- The New Jersey Technology Counsel (NJTC) N.J. Regional Commercialization Conference... is happening on November 30th, 2007. Refer to the NJTC website for announcement and details regarding this important event

10-20-07- Dr. Kiran Madura Receives Funding UMDNJ facility member and CSO of UMDNJ start-up CellXplore, Dr. Kiran Madura has received a funding commitment from Foundation Venture Capital Group, LLC. Click HERE to read the article on UMDNJ's News page or HERE for an article from VentureMagazine.com

10-15-07- The Office of Patents& Licensing has moved... The OPL would like to thank all of the depts.that continue to provide logistic services during our move. We are now at One World's Fair Drive, Somerset, N.J, 08875

6-1-07- NJCST Grant Awards Info: The N.J. Comm. on Sci. and Tech.provided $5.7M in grant awards for various research activities. Click HERE for details from UMDNJ's News Page